Oral miltefosine in post-kala-azar dermal leishmaniasis - experience in three cases

International Journal of Dermatology

Volumn 49, Issue 5, 2010, Pages 565-569

  Khandpur, Sujay ^a   Chaturvedi, Pankaj ^a   Kumar, Uttam ^a   Khaitan, Binod K ^a   Samantaray, Jyotish C ^a   Sharma, Vinod K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; DOMPERIDONE; MILTEFOSINE; PARASITE ANTIGEN; ANTIPROTOZOAL AGENT; PHOSPHORYLCHOLINE;

ADULT; ANTIGEN DETECTION; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ERYTHEMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEISHMANIA DONOVANI; LEPROSY; LUNG TUBERCULOSIS; MALE; NAUSEA; RELAPSE; SERODIAGNOSIS; SKIN BIOPSY; SKIN LEISHMANIASIS; SKIN NODULE; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; ANALOGS AND DERIVATIVES; LEISHMANIASIS, DIFFUSE CUTANEOUS; LEISHMANIASIS, VISCERAL; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; LEISHMANIASIS, DIFFUSE CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; TREATMENT OUTCOME;

EID: 77953083578     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04326.x     Document Type: Article

References (18)

1. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006, 19:111-114.
2. Ramesh V. Allopurinol therapy in post-kala-azar dermal leishmaniasis. Acta Derm Venereol 1996, 76:328-329.
3. Ramesh V, Saxena U, Misra RS. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis. Arch Dermatol 1992, 128:411-412.
4. Khalil EA, Nur NM, Zijlstra EE. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 1996, 90:187-188.
5. Sharma VK, Prasad HR, Sethuraman G. Combination of sodium stibogluconate and rifampicin in post-kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol 2007, 73:53-54.
6. Sundar S, Rosenkaimer F, Makharia MK. Trial of oral miltefosine for visceral leishmaniasis. Lancet 1998, 352:1821-1823.
7. Ramesh V, Ansari NA, Jain RK. Oral miltefosine in the treatment of post-kala-azar dermal leishmaniasis. Clin Exp Dermatol 2008, 33:103-105.
8. Sundar S, More DK, Singh MK. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000, 31:1104-1107.
9. Mishra J, Saxena A, Singh S. Chemotherapy of leishmaniasis: past, present, and future. Curr Med Chem 2007, 14:1153-1169.
10. Musa AM, Khalil EA, Mahgoub FA. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL). Ann Trop Med Parasitol 2005, 99:563-569.
11. Rakotomanga M, Saint-Pierre-Chazalet M, Loiseau PM. Alteration of fatty acid and sterol metabolism in Miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob Agents Chemother 2005, 49:2677-2686.
12. Sundar S, Jha TK, Thakur CP. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002, 347:1739-1746.
13. Bhattacharya SK, Jha TK, Sundar S. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 2004, 38:217-221.
14. Berman JJ. Treatment of leishmaniasis with miltefosine: 2008 status. Expert Opin Drug Metab Toxicol 2008, 4:1209-1216.
15. Belay AD, Asafa Y, Mesure J. Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy. Ann Trop Med Parasitol 2006, 100:223-227.
16. Guffanti M, Gaiera G, Bossolasco S. Post-kala-azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine. Am J Trop Med Hyg 2008, 79:715-718.
17. Zerpa O, Ulrich M, Blanco B. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol 2007, 156:1328-1335.
18. Calvopina M, Gomez EA, Sindermann H. Relapse of New World Diffuse Cutaneous Leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 2006, 75:1074-1077.